Early Molecular Response and Female Sex Strongly Predict Achievement of Stable Undetectable BCR-ABL1, a Criterion for Imatinib Discontinuation in Patients with CML
暂无分享,去创建一个
S. Branford | D. Yeung | Chani R Field | Haley K Altamura | D. Ross | H. Altamura | Jodi A. Prime | Jasmina Georgievski | B. A. Jamison | S. Phillis | Brad Sullivan | A. Yeoman | T. Hughes